On July 11, 2023, the U.S. Food and Drug Administration published a letter to healthcare providers stating that, based on its review of the totality of the available data and analyses,.
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a.